Patent Assignment
Reel/Frame 036747/0061
Assignment of Assignor's Interest
Recorded: 2015-10-07
Pages: 3
Assignor
FITZGERALD, KEVIN
Executed: 2015-10-02
Assignee
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, 3RD FLOOR, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property
(1)
Methods and Compositions for Treating a Disorder That Would Benefit from Reduction in Expression of a Proprotein Convertase Subtilisin Kexin (PCSK9) Gene
Application:
62/209,526 →